Comparison - IVA - NASDAQ

Weiss Ratings	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Weak
Efficiency Index	Very Weak
Solvency Index	Weak
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.31

Price History	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	0.71%
30-Day Total Return	5.33%
60-Day Total Return	38.06%
90-Day Total Return	17.21%
Year to Date Total Return	43.22%
1-Year Total Return	-18.92%
2-Year Total Return	-11.54%
3-Year Total Return	-74.78%
5-Year Total Return	--
52-Week High % Change	-22.99%
52-Week Low % Change	100.33%

Price	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$3.98
52-Week Low Price	$1.53
52-Week Low Price (Date)	Sep 26, 2024
52-Week High Price (Date)	Apr 09, 2024

Valuation	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	273.20M
Enterprise Value	342.90M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-2.25
Earnings Per Share Growth	11.27%
Price/Earnings To Growth	--
Price/Sales (TTM)	7.64
Price/Book (Q)	-1.90
Enterprise Value/Revenue (TTM)	16.44
Price	$3.07
Enterprise Value/EBITDA (TTM)	-3.25
Enterprise Value/EBIT	-3.17
Market Cap Category	Micro Cap

Dividends and Shares	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	51.98M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	33 3 80 44 75 00
Address	--
Website	www.inventivapharma.com
Country	France
Year Founded	2011

Profitability	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-518.30%
Profit Margin	-540.26%

Management Effectiveness	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-113.05%
Return on Equity	--

Income Statement	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	16.91M
Total Revenue (TTM)	20.86M
Revenue Per Share	$0.40
Gross Profit (TTM)	19.69M
EBITDA (TTM)	-105.50M
EBIT (TTM)	-108.12M
Net Income (TTM)	-112.71M
Net Income Avl. to Common (TTM)	-112.71M
Total Revenue Growth (Q YOY)	-59.17%
Earnings Growth (Q YOY)	12.28%
EPS Diluted (TTM)	-2.25
EPS Diluted Growth (Q YOY)	29.05%

Balance Sheet	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	11.18M
Cash Per Share (Q)	$0.22
Total Current Assets (Q)	30.65M
Total Preferred Equity (Q)	--
Total Equity (Q)	-84.71M
Current Ratio (Q)	0.594
Book Value Per Share (Q)	-$1.61
Total Assets (Q)	42.24M
Total Current Liabilities (Q)	51.59M
Total Debt (Q)	78.65M
Total Liabilities (Q)	126.95M
Total Common Equity (Q)	-84.71M

Cash Flow	IVA - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	9.60M
Cash from Financing (TTM)	58.21M
Net Change in Cash (TTM)	-22.81M
Levered Free Cash Flow (TTM)	-53.37M
Cash from Operations (TTM)	-91.64M